Safety and efficacy of a phage cocktail on murine wound infections caused by carbapenem-resistant Klebsiella pneumoniae

被引:2
|
作者
Feng, Yan [1 ,2 ]
Fang, Qingqing [1 ,2 ,3 ]
Luo, Huan [2 ,4 ]
Li, Juan [1 ,2 ]
Yin, Xin [1 ,2 ]
Zong, Zhiyong [1 ,2 ,4 ,5 ]
机构
[1] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Peoples R China
[2] State Key Lab Biotherapy, Div Infect Dis, Chengdu, Peoples R China
[3] Sichuan Univ, West China Hosp, Gen Practice Ward, Int Med Ctr Ward,Gen Practice Med Ctr, Chengdu, Peoples R China
[4] Sichuan Univ, West China Hosp, Ctr Pathogen Res, Chengdu, Peoples R China
[5] West China Hosp Huaxi, Ctr Infect Dis, Guoxuexiang 37, Chengdu 610041, Peoples R China
关键词
Phage therapy; Antimicrobial resistance; Carbapenem-resistant Klebsiella pneumoniae; Safety; BACTERIOPHAGE;
D O I
10.1016/j.ijantimicag.2024.107088
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
<bold>Objectives: </bold>Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a leading pathogen causing difficult-to-treat, healthcare-associated wound infections. Phages are an alternative approach against CRKP. This study established murine wound infection models with a CRKP clinical strain of sequence type 11 and capsular type KL64, which is the dominant type in China, carrying genes encoding KPC-2 and NDM-1 carbapenemases. <bold>Methods: </bold>A cocktail was made comprising three lytic phages of different viral families against the strain. The phage cocktail restricted bacterial growth for 10 hours in vitro. The efficacy and safety of the phage cocktail in treating a murine wound CRKP infection were then evaluated. Mice were randomly assigned into four groups (16 for each) comprising a phage treatment group, infected with bacteria and 30 minutes later with phages, and three control groups administered with PBS (negative control), bacteria (infection control), or phages (phage control) on the wound. Wound tissues were processed for counting bacterial loads on days 1, 3, and 7 post-infection and examined for histopathological change on days 3 and 7. Two remaining mice in each group were monitored for wound healing until day 14. <bold>Results: </bold>Compared with the infection control group, the wound bacterial load in the phage treatment group decreased by 4.95 x 10(2) CFU/g (> 100-fold; P < 0.05) at day 7 post-treatment, and wounds healed on day 10, as opposed to day 14 in the infection control group. No adverse events associated with phages were observed. <bold>Conclusion: </bold>The phage cocktail significantly reduced the wound bacterial load and promoted wound healing with good safety.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Prevalence of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae and Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae in China Determined via Mouse Lethality Tests
    Hu, Dakang
    Chen, Wenjie
    Zhang, Qi
    Li, Meng
    Yang, Zehua
    Wang, Yong
    Huang, Yunkun
    Li, Gang
    Tian, Dongxing
    Fu, Pan
    Wang, Weiwen
    Ren, Ping
    Mu, Qing
    Yu, Lianhua
    Jiang, Xiaofei
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [32] Efficacy of ceftazidime/avibactam and plazomicin on carbapenem-resistant Klebsiella pneumoniae and Escherichia coli
    Oztas, Sevil
    Er, Doganhan Kadir
    Dundar, Devrim
    Keceli, Sema Askin
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2024, 71 (02) : 110 - 120
  • [33] Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in Greece
    Karampatakis, Theodoros
    Antachopoulos, Charalampos
    Iosifidis, Elias
    Tsakris, Athanassios
    Roilides, Emmanuel
    FUTURE MICROBIOLOGY, 2016, 11 (06) : 809 - 823
  • [34] The Mobilome of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates
    Alekseeva, A. E.
    Brusnigina, N. F.
    Gordinskaya, N. A.
    RUSSIAN JOURNAL OF GENETICS, 2020, 56 (03) : 280 - 288
  • [35] The Metabolome of Carbapenem-Resistant Klebsiella pneumoniae Infection in Plasma
    Wen, Zhongwei
    Liu, Mei
    Rui, Dong
    Liao, Xiaoxiao
    Su, Rui
    Tang, Zhenming
    Wen, Zhineng
    Ling, Zhougui
    DISEASE MARKERS, 2021, 2021
  • [36] Heteroresistance to Amikacin in Carbapenem-Resistant Klebsiella pneumoniae Strains
    Zhang, Feiyang
    Li, Qin
    Bai, Jiawei
    Ding, Manlin
    Yan, Xiangjin
    Wang, Guangxi
    Zhu, Baoli
    Zhou, Yingshun
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [37] Carbapenem-resistant Klebsiella pneumoniae meningitis: A case report
    Mermer, Sinan
    Aydemir, Sohret
    Ozgiray, Ergin
    Sipahi, Oguz Resat
    JOURNAL OF CHEMOTHERAPY, 2016, 28 (05) : 454 - 455
  • [38] Persistent carbapenem-resistant Klebsiella pneumoniae: a Trojan horse
    Yang, Zhi-Qiang
    Huang, Yong-Lu
    Zhou, Hong-Wei
    Zhang, Rong
    Zhu, Kui
    LANCET INFECTIOUS DISEASES, 2018, 18 (01): : 22 - 23
  • [39] A carbapenem-resistant Klebsiella pneumoniae outbreak following bronchoscopy
    Zweigner, Janine
    Gastmeier, Petra
    Kola, Axel
    Klefisch, Frank-Rainer
    Schweizer, Christian
    Hummel, Manfred
    AMERICAN JOURNAL OF INFECTION CONTROL, 2014, 42 (08) : 936 - 937
  • [40] Hospital Readmissions in Patients With Carbapenem-Resistant Klebsiella pneumoniae
    Messina, Julia A.
    Cober, Eric
    Richter, Sandra S.
    Perez, Federico
    Salata, Robert A.
    Kalayjian, Robert C.
    Watkins, Richard R.
    Scalera, Nikole M.
    Doi, Yohei
    Kaye, Keith S.
    Evans, Scott
    Bonomo, Robert A.
    Fowler, Vance G., Jr.
    van Duin, David
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (03): : 281 - 288